Skip to content
    RXRX stock page

    RECURSION PHARMACEUTICALS, INC.

    RXRX · earnings call history

    1 call analysed
    1. Jun 2026Q2 FY26Aug 05, 2026

      Recursion Pharmaceuticals, Inc. Q2 FY26 — AI-Native Engine Drives Pipeline Progress and OpEx Efficiency

      Read the brief

    Browse all US companies on the earnings-call register.